Targeted Therapies in Non-small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Targeted Therapies in Non-small-Cell Lung Cancer

Published:2019 Issue: Volume: Page:3-43
ISSN:0927-3042
Container-title:Precision Medicine in Cancer Therapy
language:
Short-container-title:

Author:

Hill Addie,Gupta Rohan,Zhao Dan,Vankina Ritika,Amanam Idoroenyi,Salgia Ravi

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-030-16391-4_1

Reference178 articles.

1. Wheeler DA, Wang L (2013) From human genome to cancer genome: the first decade. Genome Res 23(7):1054–1062

2. Gong J et al (2018) Value-based genomics. Oncotarget 9(21):15792–15815

3. National Human Genome Research Institute (NHGRI) (2003) Human genome project completion: frequently asked questions. In: National Human Genome Research Institute (ed) 2003 release: international consortium completes HGP

4. El-Metwally S, Ouda OM, Helmy M (2014) Next generation sequencing technologies and challenges in sequence assembly. SpringerBriefs in Systems Biology, vol 7. XII, 118 11 b/w illustrations, 1 illustrations in colour. Springer-Verlag, New York

5. Mardis ER (2011) A decade’s perspective on DNA sequencing technology. Nature 470(7333):198–203

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the power of precision medicine: exploring the role of biomarkers in cancer management;Future Journal of Pharmaceutical Sciences;2024-01-05

2. Surveillance of cfDNA Hot Spot Mutations in NSCLC Patients during Disease Progression;International Journal of Molecular Sciences;2023-04-09

3. Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients;Frontiers in Oncology;2023-02-21

4. Application of diffusion kurtosis imaging and 18F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer;Frontiers in Oncology;2022-09-30

5. Circ_0002476 regulates cell growth, invasion, and mtDNA damage in non–small cell lung cancer by targeting miR ‐1182/ TFAM axis;Thoracic Cancer;2022-09-03